Mivagyn Vaginal Tablets: Clinical Study

Mivagyn vaginal tablets clinical study on vaginal pH and flora Vaginal wellbeing depends on a delicate balance between bacterial flora, mucosal hydration, and pH. A lactobacilli-dominated flora contributes to lactic acid production and helps maintain an acidic vaginal environment that is unfavorable to the proliferation of opportunistic microorganisms. When this balance is altered, symptoms such…

Graph from the Revaginal vaginal douche clinical study showing the reduction of the mean VSQ score from 5.05 to 2.89 after three weeks of treatment (p < 0.001).

Revaginal Vaginal Douche: VSQ Clinical Study

Revaginal Vaginal Douche for Intimate Wellness Revaginal vaginal douche is a medical device formulated with hyaluronic acid and lactic acid to promote vaginal mucosal hydration, help maintain physiological vaginal pH, and support intimate comfort. In a clinical study involving 20 women, the mean 16-item VSQ score decreased from 5.05 to 2.89 after 3 weeks of…

Ginox Vaginal Wash: Clinical Study

Ginox Vaginal Wash and Women’s Intimate Health Ginox Vaginal Wash is a ready-to-use solution for women’s intimate health, formulated with hyaluronic acid, lactic acid, hydrogen peroxide, and chamomile. The product helps reduce symptoms associated with an imbalance in vaginal moisture and/or pH, including dryness, burning, itching, irritation, discharge, and odor. In a clinical study involving…

MDR-Certified Vaginal Suppository: Women’s Health Milestone

Gruppo FarmaImpresa at the Top of European Quality: Maximum Safety for Gynecologic Well-Being The EU Regulation 2017/745 (MDR) is Europe’s most stringent framework for manufacturing and marketing medical devices. It raises the bar on safety, quality, and traceability, introducing far stricter requirements than previous directives. For Gruppo FarmaImpresa, obtaining MDR certification for the Class IIb…

Vaginal microbiome diversity and characteristics in PCOS

What are the different characteristics of the vaginal microbiome (VMB) between patients with polycystic ovary syndrome (PCOS) and healthy women? A cross-sectional study was conducted in a single university-affiliated academic center. 1446 participants were recruited the group with polycystic ovary syndrome consisting of 713 people and the control group consisting of 733 people. Vaginal swabs…